Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Altmueller, Janine Dr.med. (3) Blankenstein, Thomas Prof. Dr. (40) Daniel, Peter Prof. Dr. (2) Kammertöns, Thomas Dr. (8) Lee, Young-Ae Prof. Dr. (1) Pezzutto, Antonio Prof. Dr. (5) Rüschendorf, Franz Dr. (2) Uckert, Wolfgang Prof. Dr. (5) (-) Bunse, Mario Dr. (1) (-) Kopp, Joachim Dr. (2) (-) Willimsky, Gerald Dr. (12) (-) 1997 (1) 1998 (1) 2000 (3) (-) 2002 (1) (-) 2005 (4) (-) 2007 (2) 2008 (2) 2010 (4) 2011 (1) (-) 2013 (5) 2015 (2) 2016 (1) 2017 (1) 2018 (5) 2019 (3) 2020 (2) 2021 (1) 2022 (9) Developmental Biology / Signal Transduction (2) Experimental Ultrahigh-Field MR (1) Genetics, Nephrology, Hypertension, and Vascular Injury (1) Genetics of Metabolic and Reproductive Disorders (3) Molecular Cell Biology and Gene Therapy (2) (-) Molecular Immunology and Gene Therapy (13) Signal Transduction in Development and Cancer (1) 13 Results: Active Filter: Bunse, Mario Dr.Kopp, Joachim Dr.Willimsky, Gerald Dr.Molecular Immunology and Gene Therapy19972002200520072013 Sort: Result score Newest to oldest Oldest to newest August 01, 2013 in Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder March 07, 2013 in Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky March 01, 2013 in J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein February 08, 2013 in Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel February 05, 2013 in Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein December 01, 2007 in Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein October 01, 2007 in Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein September 01, 2005 in Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein July 05, 2005 in World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel January 01, 2005 in Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein Pagination Current page 1 Page 2 Next page Next › Last page Last »
August 01, 2013 in Oncotarget Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key? G. Willimsky U. Protzer P. Knolle M. Heikenwalder
March 07, 2013 in Blood Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer K. Schmidt S. Zilio J.C. Schmollinger V. Bronte T. Blankenstein G. Willimsky
March 01, 2013 in J Clin Invest Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance G. Willimsky K. Schmidt C. Loddenkemper J. Gellermann T. Blankenstein
February 08, 2013 in Mol Med High immune response rates and decreased frequencies of regulatory T cells in metastatic renal cell carcinoma patients after tumor cell vaccination H. Pohla A. Buchner B. Stadlbauer B. Frankenberger S. Stevanovic S. Walter R. Frank T. Schwachula S. Olek J. Kopp G. Willimsky C.G. Stief A. Hofstetter A. Pezzutto T. Blankenstein R. Oberneder D.J. Schendel
February 05, 2013 in Proc Natl Acad Sci U S A Fas expression by tumor stroma is required for cancer eradication J.J. Listopad T. Kammertoens K. Anders B. Silkenstedt G. Willimsky K. Schmidt A.A. Kuehl C. Loddenkemper T. Blankenstein
December 01, 2007 in Immunol Rev The adaptive immune response to sporadic cancer G. Willimsky T. Blankenstein
October 01, 2007 in Gene Ther In vivo splenic CD11c cells downregulate CD4 T-cell response thereby decreasing systemic immunity to gene-modified tumour cell vaccine S. Cayeux B. Bukarica C. Buschow J. Charo M. Bunse B. Doerken T. Blankenstein
September 01, 2005 in Nature Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance G. Willimsky T. Blankenstein
July 05, 2005 in World J Urol Cell-based vaccines for renal cell carcinoma: genetically-engineered tumor cells and monocyte-derived dendritic cells B. Frankenberger S. Regn C. Geiger E. Noessner C.S. Falk H. Pohla M. Javorovic T. Silberzahn S. Wilde A. Buchner M. Siebels R. Oberneder G. Willimsky A. Pezzutto T. Blankenstein D.J. Schendel
January 01, 2005 in Int J Cancer Tumor-induced antibodies resemble the response to tissue damage S. Preiss T. Kammertoens C. Lampert G. Willimsky T. Blankenstein
